<div id="readability-page-1"><div>ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before March 9, 2026. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Ardent did not rely on “detailed reviews of historical collections” to determine what accounts receivable were still collectable, despite its claims to investors. The Company “utilized a 180-day cliff at which time an account became fully reserved,” an approach that allowed it to delay recognizing losses on uncollectable accounts. The Company failed to maintain appropriate levels of professional malpractice liability insurance. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Ardent, investors suffered damages. Join the case to recover your losses The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. <img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjAxMTAzODExMzNyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjAxMTAzODExMzNyMQ"/> The Schall Law Firm Brian Schall, Esq., www.schallfirm.com Office: 310-301-3335 info@schallfirm.com View source version on businesswire.com: https://www.businesswire.com/news/home/20260110381133/en/</div></div>

ARDT

Schall 律师事务所提醒投资者，针对 Ardent Health, Inc.（纽约证券交易所代码：ARDT）提起的证券欺诈集体诉讼。购买了 2024 年 7 月 18 日至 2025 年 11 月 12 日期间股票的投资者，鼓励在 2026 年 3 月 9 日前联系该事务所。诉讼指控 Ardent 对其应收账款和保险水平做出了虚假陈述，导致当真相浮出水面时投资者遭受损失。该集体尚未获得认证，感兴趣的股东可以加入此案以追回损失

ARDT 投资者有机会与 Schall 律师事务所合作，主导针对 Ardent Health, Inc.的证券欺诈诉讼